Hydrocephalus: An update on latest progress in pathophysiological and therapeutic research

Area of Science:

• Neuroscience
• Medical Science

Background:

• Hydrocephalus is a critical condition caused by cerebrospinal fluid (CSF) imbalance, affecting millions worldwide across all age groups.
• Genetic mutations and post-traumatic injury are significant contributors to hydrocephalus pathology.
• Current treatments, including medications and ventriculoperitoneal (VP) shunts, offer limited efficacy and face challenges in accessibility and material quality, especially in lower-income regions.

Purpose of the Study:

• To review the pathophysiology and current treatment landscape of hydrocephalus.
• To highlight the urgent need for innovative, accessible, and low-cost therapeutic strategies.
• To explore emerging novel therapies for hydrocephalus management.

Main Methods:

• This review synthesizes information on hydrocephalus pathophysiology and existing treatments.
• It examines current advancements in pharmacological therapies, gene therapy, and nano-based technologies.
• The review assesses the clinical trial status of these novel therapeutic approaches.

Main Results:

• Existing treatments for hydrocephalus provide only symptomatic relief and have variable effectiveness.
• Significant disparities exist in treatment accessibility and outcomes, particularly between developed and developing countries.
• Novel therapeutic strategies, including pharmacological, gene, and nano-based approaches, show promise.

Conclusions:

• There is a critical need for the development of innovative, low-cost, and accessible treatments for hydrocephalus.
• Emerging therapies such as gene therapy and nano-based technologies represent promising avenues for addressing unmet needs in hydrocephalus management.
• Further research and clinical trials are essential to translate these novel strategies into effective clinical practice.